Norman Cousins Center for PNI, Semel Institute for Neuroscience, University of California, Los Angeles 90095, United States; Department of Psychiatry & Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles 90095, United States; Jonsson Comprehensive Cancer Center, University of California, Los Angeles 90095, United States.
Norman Cousins Center for PNI, Semel Institute for Neuroscience, University of California, Los Angeles 90095, United States.
Brain Behav Immun. 2019 Aug;80:839-848. doi: 10.1016/j.bbi.2019.05.034. Epub 2019 May 24.
At the M2 terminal of the macrophage activation spectrum, expression of genes is regulated by transcription factors that include STAT6, CREB, and C/EBPβ. Signaling through β-adrenergic receptors drives M2 activation of macrophages, but little is known about the transcription factors involved. In the present study, we found that C/EBPβ regulates the signaling pathway between β-adrenergic stimulation and expression of Arg1 and several other specific genes in the greater M2 transcriptome. β-adrenergic signaling induced Cebpb gene expression relatively early with a peak at 1 h post-stimulation, followed by peak Arg1 gene expression at 8 h. C/EBPβ transcription factor activity was elevated at the enhancer region for Arg 1 at both 4 and 8 h after stimulation but not near the more proximal promoter region. Knockdown of Cebpb suppressed the β-adrenergic-induced peak in Cebpb gene expression as well as subsequent accumulation of C/EBPβ protein in the nucleus, which resulted in suppression of β-adrenergic-induced Arg1 gene expression. Analysis of genome-wide transcriptional profiles identified 20 additional M2 genes that followed the same pattern of regulation by β-adrenergic- and C/EBPβ-signaling. Promoter-based bioinformatic analysis confirmed enrichment of binding motifs for C/EBPβ transcription factor across these M2 genes. These findings pinpoint a mechanism that may be targeted to redirect the deleterious influence of β-adrenergic signaling on macrophage involvement in M2-related diseases such as cancer.
在巨噬细胞激活谱的 M2 末端,基因的表达受转录因子调节,包括 STAT6、CREB 和 C/EBPβ。β-肾上腺素能受体信号传导驱动巨噬细胞的 M2 激活,但涉及的转录因子知之甚少。在本研究中,我们发现 C/EBPβ 调节 β-肾上腺素刺激和 Arg1 及更大的 M2 转录组中其他几个特定基因表达之间的信号通路。β-肾上腺素能信号诱导 Cebpb 基因表达相对较早,刺激后 1 小时达到峰值,随后 Arg1 基因表达在 8 小时达到峰值。刺激后 4 小时和 8 小时,C/EBPβ 转录因子活性在 Arg1 的增强子区域升高,但在更近端的启动子区域附近没有升高。Cebpb 敲低抑制了 β-肾上腺素诱导的 Cebpb 基因表达峰值以及随后 C/EBPβ 蛋白在核内的积累,导致 β-肾上腺素诱导的 Arg1 基因表达受到抑制。全基因组转录谱分析确定了另外 20 个 M2 基因,它们受到 β-肾上腺素和 C/EBPβ 信号的相同调控模式的调节。基于启动子的生物信息学分析证实了这些 M2 基因中 C/EBPβ 转录因子结合基序的富集。这些发现指出了一种可能的机制,该机制可能被靶向以重新引导β-肾上腺素能信号对巨噬细胞参与 M2 相关疾病(如癌症)的有害影响。